Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Lilly's new AMPA antagonist, LY-311446

Aug. 30, 1996

AChE inhibitor isolated from Penicillium at Kitasato Institute

Aug. 30, 1996

PLA2 role in Alzheimer's disease suggested

Aug. 30, 1996

Basic AD research advances reported

Aug. 30, 1996

Pfizer reports new class of muscarinic agonists

Aug. 30, 1996

CRM-1.13.1: Nicotinic agonist based on lobeline

Aug. 30, 1996

Memantine enters phase I for AIDS-related dementia, painful peripheral neuropathies

Aug. 30, 1996

Synapton phase III trials concluded

Aug. 30, 1996

Prednisone suppresses acute phase in AD patients

Aug. 30, 1996

Botulinum toxin effective in treating writer's cramp

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.